ACOART SCB BIF: Treatment of Coronary Bifurcation Lesion by Sirolimus Coated Balloon vs Paclitaxel Coated Balloon

NARecruitingINTERVENTIONAL
Enrollment

230

Participants

Timeline

Start Date

November 10, 2021

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2025

Conditions
Coronary Bifurcation Lesions
Interventions
DEVICE

Sirolimus Coated Balloon Catheter

a Sirolimus Coated Balloon Catheter designed and produced by Acotec

DEVICE

a Paclitaxel Coated Balloon Catheter

a Paclitaxel Coated Balloon Catheter(trade name:Bingo)

Trial Locations (1)

Unknown

RECRUITING

Zhongshan Hospital, Fudan University, Shanghai

Sponsors
All Listed Sponsors
collaborator

Shanghai Zhongshan Hospital

OTHER

lead

Acotec Scientific Co., Ltd

INDUSTRY

NCT04899583 - ACOART SCB BIF: Treatment of Coronary Bifurcation Lesion by Sirolimus Coated Balloon vs Paclitaxel Coated Balloon | Biotech Hunter | Biotech Hunter